Literature DB >> 8130449

Objective evaluation of radiation treatment plans.

N L Jain1, M G Kahn.   

Abstract

The evaluation of radiation treatment plans involves making trade-offs among doses delivered to the tumor volumes and nearby normal tissues. Evaluating state-of-the-art three-dimensional (3D) plans is a difficult task because of the huge amount of planning data that needs to be deciphered. Multiattribute utility theory provides a methodology for specifying trade-offs and selecting the optimal plan from many competing plans. Using multiattribute utility theory, we are developing a clinically meaningful objective plan-evaluation model for 3D radiation treatment plans. Our model incorporates three of the factors involved in radiation treatment evaluation--treatment preferences of the radiation oncologist, clinical condition of the patient, and complexity of the treatment plan.

Entities:  

Mesh:

Year:  1993        PMID: 8130449      PMCID: PMC2248491     

Source DB:  PubMed          Journal:  Proc Annu Symp Comput Appl Med Care        ISSN: 0195-4210


  4 in total

1.  Ranking radiotherapy treatment plans using decision-analytic and heuristic techniques.

Authors:  N L Jain; M G Kahn
Journal:  Comput Biomed Res       Date:  1992-08

Review 2.  Knowledge-based computer systems for radiotherapy planning.

Authors:  I J Kalet; W Paluszynski
Journal:  Am J Clin Oncol       Date:  1990-08       Impact factor: 2.339

3.  Use of transputers for real time dose calculation and presentation for three-dimensional radiation treatment planning.

Authors:  F U Rosenberger; J W Matthews; G C Johns; R E Drzymala; J A Purdy
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-03-15       Impact factor: 7.038

4.  Objective evaluation of 3-D radiation treatment plans: a decision-analytic tool incorporating treatment preferences of radiation oncologists.

Authors:  N L Jain; M G Kahn; R E Drzymala; B E Emami; J A Purdy
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-05-20       Impact factor: 7.038

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.